Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA1869 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | IL-6 | 23152.0 | 55 | |
RA1869 | TNF-a | 100 | ng/mL | 1 | IL-6 | 22399.0 | 71 | ||||
N2759 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | IL-6 | 11561.0 | 74 | |
N2759 | TNF-a | 100 | ng/mL | 1 | IL-6 | 14348.0 | 57 | ||||
RA1931 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | IL-6 | 19982.0 | 67 | |
RA1931 | TNF-a | 100 | ng/mL | 1 | IL-6 | 21943.0 | 75 | ||||
N2586 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | IL-6 | 18567.0 | 59 | |
N2586 | TNF-a | 100 | ng/mL | 1 | IL-6 | 21418.5 | 76 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-6 | 1868.0 | 53 | |
RA1869 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-6 | 11539.0 | 59 | |
N2759 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-6 | 1865.0 | 53 | |
N2759 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-6 | 9615.0 | 72 | |
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-6 | 4513.5 | 82 | |
RA1931 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-6 | 12581.0 | 46 | |
N2586 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-6 | 7921.0 | 47 | |
N2586 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-6 | 10197.0 | 53 | |
RA1869 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-6 | 33450.5 | 76 | |
RA1869 | IL-1 alpha | 100 | ng/mL | 1 | IL-6 | 32059.5 | 60 | ||||
N2759 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-6 | 32710.0 | 63 | |
N2759 | IL-1 alpha | 100 | ng/mL | 1 | IL-6 | 33839.0 | 66 | ||||
RA1931 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-6 | 34522.5 | 56 | |
RA1931 | IL-1 alpha | 100 | ng/mL | 1 | IL-6 | 35766.0 | 61 | ||||
N2586 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-6 | 36633.0 | 51 | |
N2586 | IL-1 alpha | 100 | ng/mL | 1 | IL-6 | 33645.0 | 67 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 1 | IL-6 | 2008.0 | 48 |